|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1 to 100 out of 226 for Epm2a

<< First    < Previous  |  Next >    Last >>
0.054s

Categories

Hits by Strain

Hits by Category

Type Details Score
Gene
Type: gene
Organism: human
Gene
Type: gene
Organism: cattle
Gene
Type: gene
Organism: zebrafish
Gene
Type: gene
Organism: macaque, rhesus
Gene
Type: gene
Organism: rat
Gene
Type: gene
Organism: dog, domestic
Gene
Type: gene
Organism: chimpanzee
Gene
Type: gene
Organism: chicken
Gene
Type: gene
Organism: frog, western clawed
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Gene
Type: gene
Organism: human
Gene
Type: gene
Organism: human
Publication
First Author: Wang Y
Year: 2006
Journal: Cancer Cell
Title: Epm2a suppresses tumor growth in an immunocompromised host by inhibiting Wnt signaling.
Volume: 10
Issue: 3
Pages: 179-90
Publication
First Author: Ganesh S
Year: 2001
Journal: Biochem Biophys Res Commun
Title: Regional and developmental expression of Epm2a gene and its evolutionary conservation.
Volume: 283
Issue: 5
Pages: 1046-53
Publication
First Author: Ganesh S
Year: 2002
Journal: Hum Mol Genet
Title: Targeted disruption of the Epm2a gene causes formation of Lafora inclusion bodies, neurodegeneration, ataxia, myoclonus epilepsy and impaired behavioral response in mice.
Volume: 11
Issue: 11
Pages: 1251-62
Publication
First Author: Chan EM
Year: 2004
Journal: Hum Mol Genet
Title: Laforin preferentially binds the neurotoxic starch-like polyglucosans, which form in its absence in progressive myoclonus epilepsy.
Volume: 13
Issue: 11
Pages: 1117-29
Publication
First Author: Nitschke F
Year: 2017
Journal: EMBO Mol Med
Title: Abnormal glycogen chain length pattern, not hyperphosphorylation, is critical in Lafora disease.
Volume: 9
Issue: 7
Pages: 906-917
Publication
First Author: Wang W
Year: 2007
Journal: Arch Biochem Biophys
Title: Glycogen metabolism in tissues from a mouse model of Lafora disease.
Volume: 457
Issue: 2
Pages: 264-9
Publication
First Author: Wang Y
Year: 2008
Journal: Cancer Res
Title: Laforin confers cancer resistance to energy deprivation-induced apoptosis.
Volume: 68
Issue: 11
Pages: 4039-44
Publication
First Author: Sánchez-Elexpuru G
Year: 2017
Journal: Epilepsia
Title: Sodium selenate treatment improves symptoms and seizure susceptibility in a malin-deficient mouse model of Lafora disease.
Volume: 58
Issue: 3
Pages: 467-475
Publication
First Author: Ganesh S
Year: 1999
Journal: Biochem Biophys Res Commun
Title: Isolation and characterization of mouse homologue for the human epilepsy gene, EPM2A.
Volume: 257
Issue: 1
Pages: 24-8
Publication
First Author: Tagliabracci VS
Year: 2007
Journal: Proc Natl Acad Sci U S A
Title: Laforin is a glycogen phosphatase, deficiency of which leads to elevated phosphorylation of glycogen in vivo.
Volume: 104
Issue: 49
Pages: 19262-6
Publication
First Author: Gayarre J
Year: 2014
Journal: Brain
Title: The phosphatase activity of laforin is dispensable to rescue Epm2a-/- mice from Lafora disease.
Volume: 137
Issue: Pt 3
Pages: 806-18
Publication
First Author: Liu Y
Year: 2014
Journal: Mol Neurobiol
Title: Laforin-malin complex degrades polyglucosan bodies in concert with glycogen debranching enzyme and brain isoform glycogen phosphorylase.
Volume: 49
Issue: 2
Pages: 645-57
Publication  
First Author: Burgos DF
Year: 2023
Journal: Neurobiol Dis
Title: Epm2a(R240X) knock-in mice present earlier cognitive decline and more epileptic activity than Epm2a(-/-) mice.
Volume: 181
Pages: 106119
Publication
First Author: Ganesh S
Year: 2005
Journal: Neurosci Lett
Title: Transcriptional profiling of a mouse model for Lafora disease reveals dysregulation of genes involved in the expression and modification of proteins.
Volume: 387
Issue: 2
Pages: 62-7
Publication
First Author: Wang W
Year: 2004
Journal: Biochem Biophys Res Commun
Title: Glycogen and related polysaccharides inhibit the laforin dual-specificity protein phosphatase.
Volume: 325
Issue: 3
Pages: 726-30
Publication  
First Author: Ortolano S
Year: 2014
Journal: Mol Brain
Title: Loss of GABAergic cortical neurons underlies the neuropathology of Lafora disease.
Volume: 7
Pages: 7
Publication
First Author: Ganesh S
Year: 2003
Journal: Hum Mol Genet
Title: The Lafora disease gene product laforin interacts with HIRIP5, a phylogenetically conserved protein containing a NifU-like domain.
Volume: 12
Issue: 18
Pages: 2359-68
Publication
First Author: Tiberia E
Year: 2012
Journal: J Biol Chem
Title: Increased laforin and laforin binding to glycogen underlie Lafora body formation in malin-deficient Lafora disease.
Volume: 287
Issue: 30
Pages: 25650-9
Publication
First Author: Tagliabracci VS
Year: 2008
Journal: J Biol Chem
Title: Abnormal metabolism of glycogen phosphate as a cause for Lafora disease.
Volume: 283
Issue: 49
Pages: 33816-25
Publication
First Author: DePaoli-Roach AA
Year: 2015
Journal: J Biol Chem
Title: Glycogen phosphomonoester distribution in mouse models of the progressive myoclonic epilepsy, Lafora disease.
Volume: 290
Issue: 2
Pages: 841-50
Publication
First Author: Taneja K
Year: 2021
Journal: J Comp Neurol
Title: Dendritic spine abnormalities correlate with behavioral and cognitive deficits in mouse models of Lafora disease.
Volume: 529
Issue: 6
Pages: 1099-1120
Publication
First Author: García-Cabrero AM
Year: 2012
Journal: J Neuropathol Exp Neurol
Title: Laforin and malin deletions in mice produce similar neurologic impairments.
Volume: 71
Issue: 5
Pages: 413-21
Publication
First Author: López-González I
Year: 2017
Journal: Mol Neurobiol
Title: Inflammation in Lafora Disease: Evolution with Disease Progression in Laforin and Malin Knock-out Mouse Models.
Volume: 54
Issue: 5
Pages: 3119-3130
Publication  
First Author: García-Cabrero AM
Year: 2014
Journal: Front Neurosci
Title: Enhanced sensitivity of laforin- and malin-deficient mice to the convulsant agent pentylenetetrazole.
Volume: 8
Pages: 291
Publication
First Author: Romá-Mateo C
Year: 2015
Journal: Mol Neurobiol
Title: Increased oxidative stress and impaired antioxidant response in Lafora disease.
Volume: 51
Issue: 3
Pages: 932-46
Publication
First Author: Vernia S
Year: 2009
Journal: PLoS One
Title: Increased endoplasmic reticulum stress and decreased proteasomal function in lafora disease models lacking the phosphatase laforin.
Volume: 4
Issue: 6
Pages: e5907
Publication
First Author: Zeng L
Year: 2012
Journal: FEBS J
Title: Laforin is required for the functional activation of malin in endoplasmic reticulum stress resistance in neuronal cells.
Volume: 279
Issue: 14
Pages: 2467-78
Publication  
First Author: Burgos DF
Year: 2020
Journal: Int J Mol Sci
Title: Structural and Functional Brain Abnormalities in Mouse Models of Lafora Disease.
Volume: 21
Issue: 20
Publication
First Author: Puri R
Year: 2009
Journal: J Biol Chem
Title: Hyperphosphorylation and aggregation of Tau in laforin-deficient mice, an animal model for Lafora disease.
Volume: 284
Issue: 34
Pages: 22657-63
Publication
First Author: Rai A
Year: 2017
Journal: Hum Mol Genet
Title: Suppression of leptin signaling reduces polyglucosan inclusions and seizure susceptibility in a mouse model for Lafora disease.
Volume: 26
Issue: 24
Pages: 4778-4785
Publication
First Author: DePaoli-Roach AA
Year: 2012
Journal: Hum Mol Genet
Title: Laforin and malin knockout mice have normal glucose disposal and insulin sensitivity.
Volume: 21
Issue: 7
Pages: 1604-10
Publication
First Author: Garyali P
Year: 2014
Journal: J Biol Chem
Title: Protein degradation and quality control in cells from laforin and malin knockout mice.
Volume: 289
Issue: 30
Pages: 20606-14
Publication
First Author: Liu R
Year: 2008
Journal: Mol Cell Biol
Title: Laforin negatively regulates cell cycle progression through glycogen synthase kinase 3beta-dependent mechanisms.
Volume: 28
Issue: 23
Pages: 7236-44
Publication  
First Author: Upadhyay M
Year: 2017
Journal: Neurobiol Dis
Title: Loss of laforin or malin results in increased Drp1 level and concomitant mitochondrial fragmentation in Lafora disease mouse models.
Volume: 100
Pages: 39-51
Protein Coding Gene
Type: protein_coding_gene
Organism: Mus caroli
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: Mus pahari
Protein Coding Gene
Type: protein_coding_gene
Organism: Mus spretus
Publication
First Author: Liu Y
Year: 2006
Journal: J Biol Chem
Title: Dimerization of Laforin is required for its optimal phosphatase activity, regulation of GSK3beta phosphorylation, and Wnt signaling.
Volume: 281
Issue: 46
Pages: 34768-74
Publication
First Author: Zheng X
Year: 2002
Journal: J Immunol
Title: Clonal deletion of simian virus 40 large T antigen-specific T cells in the transgenic adenocarcinoma of mouse prostate mice: an important role for clonal deletion in shaping the repertoire of T cells specific for antigens overexpressed in solid tumors.
Volume: 169
Issue: 9
Pages: 4761-9
Publication
First Author: Geiger T
Year: 1992
Journal: Proc Natl Acad Sci U S A
Title: T-cell responsiveness to an oncogenic peripheral protein and spontaneous autoimmunity in transgenic mice.
Volume: 89
Issue: 7
Pages: 2985-9
Publication
First Author: Garbi N
Year: 2004
Journal: J Immunol
Title: CpG motifs as proinflammatory factors render autochthonous tumors permissive for infiltration and destruction.
Volume: 172
Issue: 10
Pages: 5861-9
Publication
First Author: Newman B
Year: 2012
Journal: Cancer Res
Title: HSP90 inhibitor 17-AAG selectively eradicates lymphoma stem cells.
Volume: 72
Issue: 17
Pages: 4551-61
Publication
First Author: Guerder S
Year: 1995
Journal: J Immunol
Title: B7 costimulation is necessary for the activation of the lytic function in cytotoxic T lymphocyte precursors.
Volume: 155
Issue: 11
Pages: 5167-74
Publication
First Author: Irimia JM
Year: 2015
Journal: J Biol Chem
Title: Muscle glycogen remodeling and glycogen phosphate metabolism following exhaustive exercise of wild type and laforin knockout mice.
Volume: 290
Issue: 37
Pages: 22686-98
Publication
First Author: Machado-Salas J
Year: 2012
Journal: Exp Neurol
Title: Ontogeny of Lafora bodies and neurocytoskeleton changes in Laforin-deficient mice.
Volume: 236
Issue: 1
Pages: 131-40
Publication
First Author: Singh PK
Year: 2013
Journal: Mol Biol Cell
Title: Activation of serum/glucocorticoid-induced kinase 1 (SGK1) underlies increased glycogen levels, mTOR activation, and autophagy defects in Lafora disease.
Volume: 24
Issue: 24
Pages: 3776-86
Publication
First Author: Singh PK
Year: 2012
Journal: Mol Cell Biol
Title: The laforin-malin complex negatively regulates glycogen synthesis by modulating cellular glucose uptake via glucose transporters.
Volume: 32
Issue: 3
Pages: 652-63
Publication
First Author: Wang Y
Year: 2013
Journal: Mol Neurobiol
Title: Laforin prevents stress-induced polyglucosan body formation and Lafora disease progression in neurons.
Volume: 48
Issue: 1
Pages: 49-61
Publication
First Author: Puri R
Year: 2012
Journal: Hum Mol Genet
Title: Dysfunctions in endosomal-lysosomal and autophagy pathways underlie neuropathology in a mouse model for Lafora disease.
Volume: 21
Issue: 1
Pages: 175-84
Publication
First Author: Vernia S
Year: 2011
Journal: Hum Mol Genet
Title: Laforin, a dual specificity phosphatase involved in Lafora disease, regulates insulin response and whole-body energy balance in mice.
Volume: 20
Issue: 13
Pages: 2571-84
GXD Expression      
Probe: MGI:3839017
Assay Type: Northern blot
Annotation Date: 2009-04-08
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1603910
Stage: TS10
Assay Id: MGI:3839018
Age: embryonic day 7.0
Specimen Label: 7 dpc
Detected: false
Specimen Num: 1
GXD Expression      
Probe: MGI:3839017
Assay Type: Northern blot
Annotation Date: 2009-04-08
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1603918
Stage: TS18
Assay Id: MGI:3839018
Age: embryonic day 11.0
Specimen Label: 11 dpc
Detected: false
Specimen Num: 2
GXD Expression      
Probe: MGI:3839017
Assay Type: Northern blot
Annotation Date: 2009-04-08
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1603923
Stage: TS23
Assay Id: MGI:3839018
Age: embryonic day 15.0
Specimen Label: 15 dpc
Detected: false
Specimen Num: 3
GXD Expression      
Probe: MGI:3839017
Assay Type: Northern blot
Annotation Date: 2009-04-08
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1603925
Stage: TS25
Assay Id: MGI:3839018
Age: embryonic day 17.0
Specimen Label: 17 dpc
Detected: true
Specimen Num: 4
GXD Expression      
Probe: MGI:3839017
Assay Type: Northern blot
Annotation Date: 2009-04-08
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1689427
Stage: TS27
Assay Id: MGI:3839020
Age: postnatal day 0
Specimen Label: 0 day
Detected: true
Specimen Num: 1
GXD Expression      
Probe: MGI:3839017
Assay Type: Northern blot
Annotation Date: 2009-04-08
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1689428
Stage: TS28
Assay Id: MGI:3839020
Age: postnatal day 10
Specimen Label: 10 day
Detected: true
Specimen Num: 2
GXD Expression      
Probe: MGI:3839017
Assay Type: Northern blot
Annotation Date: 2009-04-08
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1689428
Stage: TS28
Assay Id: MGI:3839020
Age: postnatal day 20
Specimen Label: 20 day
Detected: true
Specimen Num: 3
GXD Expression      
Probe: MGI:3839017
Assay Type: Northern blot
Annotation Date: 2009-04-08
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1689428
Stage: TS28
Assay Id: MGI:3839020
Age: postnatal day 40
Specimen Label: 40 day
Detected: true
Specimen Num: 4
GXD Expression      
Probe: MGI:3839017
Assay Type: Northern blot
Annotation Date: 2009-04-08
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1689428
Stage: TS28
Assay Id: MGI:3839020
Age: postnatal day 80
Specimen Label: 80 day
Detected: true
Specimen Num: 5
GXD Expression      
Probe: MGI:3839017
Assay Type: Northern blot
Annotation Date: 2009-04-08
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1689428
Stage: TS28
Assay Id: MGI:3839020
Age: postnatal day 160
Specimen Label: 160 day
Detected: true
Specimen Num: 6
GXD Expression    
Probe: MGI:3839017
Assay Type: RNA in situ
Annotation Date: 2009-04-08
Strength: Moderate
Sex: Not Specified
Emaps: EMAPS:1754928
Pattern: Not Specified
Stage: TS28
Assay Id: MGI:3839021
Age: postnatal adult
Specimen Label: 6A
Detected: true
Specimen Num: 1
GXD Expression    
Probe: MGI:3839017
Assay Type: RNA in situ
Annotation Date: 2009-04-08
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:1778728
Pattern: Not Specified
Stage: TS28
Assay Id: MGI:3839021
Age: postnatal adult
Specimen Label: 6A
Detected: true
Specimen Num: 1
GXD Expression    
Probe: MGI:3839017
Assay Type: RNA in situ
Annotation Date: 2009-04-08
Strength: Moderate
Sex: Not Specified
Emaps: EMAPS:1754428
Pattern: Not Specified
Stage: TS28
Assay Id: MGI:3839021
Age: postnatal adult
Specimen Label: 6A
Detected: true
Specimen Num: 1
GXD Expression    
Probe: MGI:3839017
Assay Type: RNA in situ
Annotation Date: 2009-04-08
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:3284528
Pattern: Not Specified
Stage: TS28
Assay Id: MGI:3839021
Age: postnatal adult
Specimen Label: 6A
Detected: true
Specimen Num: 1
GXD Expression    
Probe: MGI:3839017
Assay Type: RNA in situ
Annotation Date: 2009-04-08
Strength: Very strong
Sex: Not Specified
Emaps: EMAPS:3522328
Pattern: Not Specified
Stage: TS28
Assay Id: MGI:3839021
Age: postnatal adult
Specimen Label: 6B
Detected: true
Specimen Num: 2
GXD Expression    
Probe: MGI:3839017
Assay Type: RNA in situ
Annotation Date: 2009-04-08
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:3560828
Pattern: Not Specified
Stage: TS28
Assay Id: MGI:3839021
Age: postnatal adult
Specimen Label: 6C
Detected: true
Specimen Num: 3
GXD Expression    
Probe: MGI:3839017
Assay Type: RNA in situ
Annotation Date: 2009-04-08
Strength: Moderate
Sex: Not Specified
Emaps: EMAPS:1754028
Pattern: Not Specified
Stage: TS28
Assay Id: MGI:3839021
Age: postnatal adult
Specimen Label: 6A
Detected: true
Specimen Num: 1
GXD Expression    
Probe: MGI:3839017
Assay Type: RNA in situ
Annotation Date: 2009-04-08
Strength: Moderate
Sex: Not Specified
Emaps: EMAPS:3280928
Pattern: Not Specified
Stage: TS28
Assay Id: MGI:3839021
Age: postnatal adult
Specimen Label: 6A
Detected: true
Specimen Num: 1
GXD Expression    
Probe: MGI:3839017
Assay Type: RNA in situ
Annotation Date: 2009-04-08
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:3561128
Pattern: Not Specified
Stage: TS28
Assay Id: MGI:3839021
Age: postnatal adult
Specimen Label: 6C
Detected: true
Specimen Num: 3
Publication
First Author: Criado O
Year: 2012
Journal: Hum Mol Genet
Title: Lafora bodies and neurological defects in malin-deficient mice correlate with impaired autophagy.
Volume: 21
Issue: 7
Pages: 1521-33
Publication
First Author: Nitschke F
Year: 2013
Journal: Cell Metab
Title: Hyperphosphorylation of glucosyl C6 carbons and altered structure of glycogen in the neurodegenerative epilepsy Lafora disease.
Volume: 17
Issue: 5
Pages: 756-67
Publication
First Author: Turnbull J
Year: 2011
Journal: PLoS Genet
Title: PTG depletion removes Lafora bodies and rescues the fatal epilepsy of Lafora disease.
Volume: 7
Issue: 4
Pages: e1002037